Literature DB >> 9836677

Secondary prevention in coronary heart disease. Cost effectiveness of treatment must be borne in mind.

R E Ferner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9836677      PMCID： PMC1114402          DOI： 10.1136/bmj.317.7172.1592

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

2.  The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment.

Authors:  M G Hunink; L Goldman; A N Tosteson; M A Mittleman; P A Goldman; L W Williams; J Tsevat; M C Weinstein
Journal:  JAMA       Date:  1997-02-19       Impact factor: 56.272

3.  Secondary prevention in coronary heart disease: baseline survey of provision in general practice.

Authors:  N C Campbell; J Thain; H G Deans; L D Ritchie; J M Rawles
Journal:  BMJ       Date:  1998-05-09

4.  Secondary prevention clinics for coronary heart disease: randomised trial of effect on health.

Authors:  N C Campbell; J Thain; H G Deans; L D Ritchie; J M Rawles; J L Squair
Journal:  BMJ       Date:  1998-05-09

5.  Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed?

Authors:  A K McCallum; P H Whincup; R W Morris; A Thomson; M Walker; S Ebrahim
Journal:  Br J Gen Pract       Date:  1997-07       Impact factor: 5.386

6.  A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

Authors:  T J Bowker; T C Clayton; J Ingham; N R McLennan; H L Hobson; S D Pyke; B Schofield; D A Wood
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

7.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

8.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321
  8 in total
  1 in total

1.  Secondary prevention in coronary heart disease. Effects of statins have been in addition to those of aspirin and beta blockers.

Authors:  J Morrell
Journal:  BMJ       Date:  1999-05-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.